ARTICLE | Company News
Cell Signaling Technology, J&J deal
July 18, 2005 7:00 AM UTC
JNJ's Johnson & Johnson Pharmaceutical Research & Development unit will use Cell Signaling's PhosphoScan proteomics technology to identify phosphorylation sites on kinase targets. ...